| Literature DB >> 34002916 |
Giovanni Pellegrino1, Tanguy Hedrich2, Viviane Sziklas1, Jean-Marc Lina3,4, Christophe Grova1,2,4,5, Eliane Kobayashi1.
Abstract
Interactions between interictal epileptiform discharges (IEDs) and distant cortical regions subserve potential effects on cognition of patients with focal epilepsy. We hypothesize that "healthy" brain areas at a distance from the epileptic focus may respond to the interference of IEDs by generating inhibitory alpha and beta oscillations. We predict that more prominent alpha-beta oscillations can be found in patients with less impaired neurocognitive profile. We performed a source imaging magnetoencephalography study, including 41 focal epilepsy patients: 21 with frontal lobe epilepsy (FLE) and 20 with mesial temporal lobe epilepsy. We investigated the effect of anterior (i.e., frontal and temporal) IEDs on the oscillatory pattern over posterior head regions. We compared cortical oscillations (5-80 Hz) temporally linked to 3,749 IEDs (1,945 frontal and 1,803 temporal) versus an equal number of IED-free segments. We correlated results from IED triggered oscillations to global neurocognitive performance. Only frontal IEDs triggered alpha-beta oscillations over posterior head regions. IEDs with higher amplitude triggered alpha-beta oscillations of higher magnitude. The intensity of posterior head region alpha-beta oscillations significantly correlated with a better neuropsychological profile. Our study demonstrated that cerebral cortex protects itself from IEDs with generation of inhibitory alpha-beta oscillations at distant cortical regions. The association of more prominent oscillations with a better cognitive status suggests that this mechanism might play a role in determining the cognitive resilience in patients with FLE.Entities:
Keywords: alpha; beta; epilepsy; inhibition; interictal epileptiform discharges; magnetoencephalography; oscillations
Mesh:
Year: 2021 PMID: 34002916 PMCID: PMC8249896 DOI: 10.1002/hbm.25422
Source DB: PubMed Journal: Hum Brain Mapp ISSN: 1065-9471 Impact factor: 5.038
FIGURE 1Region of interest (ROI)‐based analysis: (a) In red the 6 ROIs considered for time‐frequency (TF) analysis. (b) Average magnetoencephalography (MEG) interictal epileptiform discharges (IEDs) signal for all patients (left column), frontal lobe epilepsy (FLE) patients (middle column) and mesial temporal lobe epilepsy (TLE) patients (right column). To avoid cancelation phenomena, the absolute value of MEG signal was extracted prior to computing average IEDs. The magenta and cyan bands refer to the time window considered in (d). (c) Statistical maps of IEDs effect, with the color scale indicating the magnitude of the group‐level t value. The maps have been thresholded and only report significant clusters after permutation statistics (p < .05). Each row refers to the corresponding ROI in (a), each column refers to the patients' group indicated in (b). TF analysis was centered around IEDs (from −1 to 1 s) and from 5 to 80 Hz. IEDs triggered alpha‐beta oscillations in the posterior head regions, with a maximum at about 12–16 Hz and a duration up to 1 s after IEDs. This effect was appreciated in the entire cohort (left column), was very similar for FLE patients and absent in TLE patients. (d) Patients' specific t values for oscillations triggered at 12–16 Hz and between 0.5 and 0.9 s after IEDs versus control markers, computed at the ROI level (as indicated in [a]), for both groups. Each bar corresponds to one patient. Magenta bars (frontal patients) consistently show positive t values. Cyan bars (temporal patients) fluctuate around zero
Subjects and IEDs included in the analysis
| All | Frontal | Temporal | Left hem | Right hem | Left frontal | Right frontal | ||
|---|---|---|---|---|---|---|---|---|
| Number of subjects | 41 | 21 | 20 | 18 | 23 | 10 | 11 | |
| IEDs | Total number | 3,749 | 1,945 | 1,803 | 1,962 | 1,786 | 791 | 1,154 |
| Average/subject | 91 | 93 | 90 | 109 | 78 | 79 | 105 | |
| Median/subject | 67 | 69 | 55 | 70 | 57 | 68 | 126 | |
| Maximum/subject | 413 | 239 | 413 | 413 | 203 | 239 | 203 | |
| Minimum/subject | 10 | 19 | 10 | 14 | 10 | 19 | 20 | |
Note: The number of subjects and spikes was comparable across groups, sides, hemispheres.
Abbreviation: IEDs, interictal epileptiform discharges.
FIGURE 2(a) Average spike across all patients. Absolute values of magnetoencephalography (MEG) signal were extracted prior to computing the group level average spike. (b) Time‐frequency analysis was restricted to the posterior head region, as highlighted in different color‐coded regions of interest, to avoid potential volume conduction effects with the main generators of the interictal epileptiform discharges (IEDs). (c) Statistical maps showing the distribution of significant increases in alpha/beta oscillations (12–16 Hz range) in the posterior head regions at different time points along the IEDs, for the entire cohort (first row), frontal lobe epilepsy (FLE) patients (second row) and mesial temporal lobe epilepsy (TLE) patients (third row). Cortical surface has been inflated to improve visibility of represented sources. Note that the FLE group showed a significant, sustained and quite widespread increase of alpha/beta oscillations in bilateral posterior cerebral cortices
FIGURE 3(a) Average map of the correlation between alpha/beta oscillations generated in the posterior head regions and cognitive performance. Red indicates positive relationship, with more alpha/beta corresponding to better cognitive performance. L = Left, P = Posterior. (b) Map of the cluster with a significant relationship (p = .037) between alpha/beta oscillation and cognition after correction for multiple comparisons with cluster‐based permutation approach. (c) Scatterplot of the correlation of data extracted from the cluster reported in (b)
Patients' clinical features
| ID | Epilepsy classification | Focus side | Age (years) | Seizures preferentially during sleep | MRI findings | AEDs |
|---|---|---|---|---|---|---|
| 1 | Frontal | Left | 27 | Yes | Left orbitofrontal encephalocele | LEV, LTG |
| 2 | Frontal | Left | 24 | Left frontal parasagittal FCD | LTG | |
| 3 | Frontal | Left | 31 | Left frontal PMG | CBZ, LEV, CLB | |
| 4 | Frontal | Left | 35 | Yes | Left orbitofrontal FCD | LCM, PHT |
| 5 | Frontal | Left | 19 | Yes | Left frontal opercular FCD | CBZ, CLB |
| 6 | Frontal | Left | 30 | Yes | Left frontal FCD | PHT, LTG |
| 7 | Frontal | Left | 35 | Yes | No MRI lesion | LEV, LTG |
| 8 | Frontal | Left | 28 | Left anterior cingulate FCD | CBZ, LCM, CLB | |
| 9 | Frontal | Left | 52 | No MRI lesion | LTG, CBZ | |
| 10 | Frontal | Left | 30 | No MRI lesion | PHT, LCM | |
| 11 | Frontal | Right | 32 | Right hemimegalencephaly | LEV, OXC, CLB | |
| 12 | Frontal | Right | 15 | Right frontal FCD | CBZ, CLB | |
| 13 | Frontal | Right | 15 | Yes | Right frontal FCD | OXC, CLB |
| 14 | Frontal | Right | 20 | Yes | Right frontal FCD | CBZ, CLB |
| 15 | Frontal | Right | 32 | Right hemimegalencephaly | LEV, OXC, CLB | |
| 16 | Frontal | Right | 41 | Yes | No MRI lesion | PB, LEV, CLB |
| 17 | Frontal | Right | 22 | Right frontal FCD | VPA, LTG | |
| 18 | Frontal | Right | 34 | Yes | Right frontal FCD | LEV, PB, GBP |
| 19 | Frontal | Right | 29 | Yes | Right frontal FCD | VPA, OXC |
| 20 | Frontal | Right | 21 | Yes | No MRI lesion | PHT, CBZ, LTG, CLB |
| 21 | Frontal | Right | 35 | Yes | No MRI lesion | CBZ, LEV |
| 22 | Temporal | Left | 42 | Left hippocampal atrophy | PHT, LTG, TPM | |
| 23 | Temporal | Left | 29 | Left hippocampal atrophy | CBZ | |
| 24 | Temporal | Left | 29 | Left amygdala signal abnormality | LEV, CLB | |
| 25 | Temporal | Left | 13 | Yes | Left hippocampal malrotation | LEV, TPM, PHT |
| 26 | Temporal | Left | 38 | Left hippocampus malrotation | LEV | |
| 27 | Temporal | Left | 33 | Left hippocampal atrophy | OXC, LTG | |
| 28 | Temporal | Left | 46 | Left hippocampal atrophy | CBZ, OXC, TPM, LCM | |
| 29 | Temporal | Left | 23 | Left hippocampal atrophy | CBZ | |
| 30 | Temporal | Right | 40 | Right hippocampal atrophy | LEV | |
| 31 | Temporal | Right | 58 | Right hippocampal atrophy | OXC, CLB | |
| 32 | Temporal | Right | 31 | Right hippocampal atrophy | CBZ, CLB | |
| 33 | Temporal | Right | 19 | Right hippocampal atrophy | LEV | |
| 34 | Temporal | Right | 34 | Right hippocampal atrophy | LTG, TPM, CBZ | |
| 35 | Temporal | Right | 23 | Right hippocampal atrophy | CBZ, LTG, TPM | |
| 36 | Temporal | Right | 23 | Right hippocampal atrophy | CBZ | |
| 37 | Temporal | Right | 39 | Right hippocampal atrophy | LEV, CBZ | |
| 38 | Temporal | Right | 32 | Right hippocampal atrophy | LAM | |
| 39 | Temporal | Right | 19 | Right hippocampal atrophy | GBP, CLB | |
| 40 | Temporal | Right | 25 | Right hippocampal atrophy | OXC, LTG | |
| 41 | Temporal | Right | 55 | Right hippocampal atrophy | OXC, CLB, LEV |
Abbreviations: CBZ, carbamazepine; CLB, clobazam; FCD, focal cortical dysplasia; GBP, gabapentin; LCM, lacosamide; LEV, levetiracetam; LTG, lamotrigine; OXC, oxcarbazepine; PB, phenobarbital; PHT, phenytoin; PMG, polymicrogyria; VPA, valproic acid.